People · Operator

Jeffrey S. Leiden

Named in public records as an officer, director or promoter · active 2010–2010 · Other

1
Companies
1
Filings
$40.7M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
TYRX, Inc.OtherSeries B$40.7M$33.2M2010
Operator network

Jeffrey S. Leiden at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Scott Requadt · 5 companies · 1 sharedScott RequadtArthur Pappas · 3 companies · 1 sharedArthur PappasRobert S White · 3 companies · 1 sharedRobert S WhiteWilliam Edelman · 3 companies · 1 sharedWilliam EdelmanArthur S. Pappas · 2 companies · 1 sharedArthur S. PappasJEFF LEIDEN · 2 companies · 1 sharedJEFF LEIDENArikha Moses · 1 companies · 1 sharedArikha MosesCharles Cahn · 1 companies · 1 sharedCharles CahnEdward G. Cahill · 1 companies · 1 sharedEdward G. CahillMichael T. Heffernan · 1 companies · 1 sharedMichael T. Heffer…Mike Heffernan · 1 companies · 1 sharedMike HeffernanRay Imp · 1 companies · 1 sharedRay ImpRay S. Imp · 1 companies · 1 sharedRay S. ImpScott S. Requadt · 1 companies · 1 sharedScott S. RequadtWilliam G. Dempsey · 1 companies · 1 sharedWilliam G. DempseyWilliam S. Young · 1 companies · 1 sharedWilliam S. YoungTYRX, Inc. · $40.7M raisedTYRX, Inc.Jeffrey S. LeidenJL
Jeffrey S. Leiden Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Jeffrey S. Leiden on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Scott Requadt15
William Edelman13
Robert S White13
Arthur Pappas13
JEFF LEIDEN12
Arthur S. Pappas12
Edward G. Cahill11
Mike Heffernan11
Ray Imp11
Charles Cahn11
Arikha Moses11
William G. Dempsey11
Scott S. Requadt11
William S. Young11
Michael T. Heffernan11
Ray S. Imp11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.